Bergen County Top Doctors 2021

Bergen Magazine Names Bergen County’s Top Docs 2021

We are proud to announce that 10 New Jersey Urology physicians have been honored as 2021 Bergen County’s Top Doctors by BERGEN Magazine.

Bergen County is home to some of the most prominent and sought-after physicians in the country. BERGEN magazine commissioned Professional Research Services (PRS) of Troy, Michigan to select the finalists. All final honorees were fact-checked with the State of New Jersey and the New Jersey Division of Consumer Affairs License Verification System.

Congratulations to our esteemed urologists from our Englewood, Maywood and Teaneck locations!

 

2021 BERGEN COUNTY’S TOP DOCS:

See BERGEN Magazine’s complete list of top doctors here >

NJU Physicians Selected as NJ Top Docs 2021

NJ Top Docs has released the latest issue of Healthy Living Magazine which features all reviewed and approved NJ Top Doctors of 2021. We’re proud to announce that 21 New Jersey Urology physicians have made the list this year!

Congratulations to our physicians who were named NJ Top Docs:

To view all 2021 NJ Top Doctors, turn to page 69 in the digital edition >

GreenLight_Hero_Image

Dr. Marc Feder Designated as a Center of Excellence for GreenLight™ Laser Therapy

Dr. Marc Feder GreenLight Laser Therapy Center of ExcellenceCenter of Excellence Recognizes High Degree of Experience with New Technology

We’re pleased to announce that Dr. Marc Feder has been designated as a Center of Excellence for GreenLight™ Laser Therapy treatment – a minimally invasive outpatient procedure for men looking to treat their benign prostatic hyperplasia (BPH), not just the symptoms. GreenLight Therapy can help provide immediate relief from enlarged prostate symptoms such as frequent urination—especially at night, weak urine flow, urgency and incomplete bladder emptying. In addition, GreenLight Laser Therapy requires no incisions and typically has no overall deleterious impact on sexual function.1 The Center of Excellence designation recognizes Dr. Feder’s high degree of experience with GreenLight Laser Therapy and commitment to delivering effective, long-lasting therapy to men suffering from BPH.1

BPH is a condition in which a man’s prostate enlarges and squeezes the urethra, causing frustrating symptoms such as frequent or urgent urination, a weak or interrupted urine stream, and the need to get up several times a night to urinate. It affects about 50% of men by age 60, and up to 90% of men by age 85.2

“I am very excited to receive the designation as the first GreenLight Center of Excellence in New Jersey” said Dr. Marc Feder.

“The urologists in our group provide the full spectrum of BPH management, including dietary modification, medications, REZUM, Greenlight laser and surgery for large glands. The Greenlight laser technology allows for rapid relief of BPH symptoms in a minimally invasive approach with immediate improvement in quality of life.”

GreenLight Laser Therapy uses laser energy to vaporize the enlarged tissue, creating an open channel for urine to pass through the urethra. In addition to typically experiencing immediate improvements in urine flow, many patients are pleased to know that GreenLight typically has no overall deleterious impact on sexual function.1 GreenLight Laser therapy is a long-term solution without the need for BPH medication.1

GreenLight Therapy is currently being used in many leading urology practices throughout the United States. To date, more than 1 million patients around the world have been successfully treated with GreenLight Therapy.3

 


1. Bachmann A, Tubaro A, Barber N, et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight-XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol. 2015 Feb;193(2):570-8.

2. What is BPH? Urology Care Foundation website. https://www.urologyhealth.org/urologic-conditions/benign-prostatic-hyperplasia-(bph).

3. Data on file with Boston Scientific.

* Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.

IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural

New Jersey Urology Named The Best Urology Practice in Burlington County

We’re proud to announce that New Jersey Urology has been honored by the Burlington County Times as The Best of the Best 2020! Organizations on this list have been selected by the readers and represent the finest businesses in Burlington County, New Jersey.

Burlington County Times 2020 Best of the Best :

Congratulations to all the winners!

See Burlington County Time’s complete list here (Best Urology Category – 11:36) >

 


Dr. Mutahar Ahmed - Urologic Surgeon - da Vinci Single Port Robotic Surgery

Pioneers in Single Port Robotic Surgery

Photo Credit: Hackensack University Medical Center

New Jersey Urology becomes the leading center in the northeast to offer single port robotic surgery for bladder cancer

New Jersey Urology is among the first in the world to perform the da Vinci single port robotic surgery.

NJU, renowned leader and center of excellence in robotic surgery for twenty years, is the first and only in the northeast to offer single port robotic surgery for bladder cancer. The single port robotic radical cystectomy — a procedure to treat bladder cancer by removing the entire bladder — is performed at Hackensack University Medical Center through a single three-centimeter incision using the da Vinci SP® Surgical System. NJU also specializes in a plethora of other robotic cancer and reconstructive surgeries. This center is the most experienced with these procedures, and have advanced their techniques to perfection.

Since 2016, Mutahar Ahmed, M.D. serves as the Director, Urologic Bladder Cancer Program at Hackensack University Medical Center. He has completed 15 single port robotic radical cystectomies since then, establishing him as one of the most experienced surgeons in the world at performing this highly specialized procedure.

“We have one of the highest volumes of robotic cystectomy centers in the country. Now we have added the single port surgery to our repertoire, which allows us to provide state-of-the-art care to our patients,” said Dr. Ahmed.

Standard robotic laparoscopic surgeries require 5-6 small incisions, whereas the revolutionary single port robotic procedure combines them into one keyhole incision. Most radical cystectomies at other centers are still performed using traditional open surgery techniques. Only a handful are being performed using this innovative single port robotic surgery, while NJU specializes in minimizing incisions. In addition to removing the bladder, surgeons perform urinary reconstruction to create a new way for urine to collect and exit the body.

Aside from Radical cystectomy we also perform other urological cancer surgery using the single port robot such as:

  • Radical prostatectomy
  • Partial nephrectomy
  • Other reconstructive surgeries like Ureteropelvic Junction Obstruction (UPJ) repairs

Robotic cystectomies have been shown to provide cancer treatment that is just as effective as traditional open surgery. The highly specialized robotic surgery benefits include:

  • Less discomfort
  • Shorter hospital stay
  • Faster recovery
  • Improved cosmetic results for patients

In the past five years, NJU urologists have performed more than 250 robotic cystectomies. NJU’s urological surgeons are now performing between 60 and 70 robotic cystectomy procedures each year — which is the highest annual volume of robotic cystectomies performed in New Jersey.

NJU Physicians Selected as New Jersey Monthly 2020 Top Doctors

We’re proud to announce that 16 New Jersey Urology physicians have been honored as 2020 Jersey Choice Top Doctors by New Jersey Monthly Magazine.

More than 25,000 New Jersey–based doctors were invited to recommend the physicians they would choose to treat their own family members.

2020 Jersey Choice Top Doctors in Urology:

See New Jersey Monthly’s complete list here >

New Jersey Urology Epic EHR

New Jersey Urology is the First-Ever Urology Group to Launch Epic’s Electronic Health Record

5 Oct 2020 News ,

Bloomfield, NJ, October 5, 2020 – New Jersey Urology (“NJU”), the leading urology service provider in New Jersey, and Urology Management Associates (“UMA”), NJU’s administrative practice management, are pleased to announce the launch of its urologic-centric Epic electronic health record. NJU is the first urology-only group to launch Epic.

“As one of our key strategic priorities for NJU, we are proud to launch the first-ever instance of Epic that was designed, configured, and tailored to address the specialized [specific] workflows of urologic care,” said Scott Ciccarelli, CEO of NJU. “Our unique collaboration with Epic will help us to redefine clinical standards of excellence and will improve urological patient care across the nation.”

“Patients are best served when physician specialists have access to their patients’ full health history,” said Jeff Trinkl, MD, Director of Clinical Informatics at Epic. “As an example, when treating specific conditions, like prostate cancer, urologists need access to other information that could affect the course of care, such as a patient’s medications and underlying health conditions. In Epic, specialty-specific information and the broader picture of a person’s health is all in one place.”

Epic is ranked as the #1 Overall Software Suite by KLAS, an independent healthcare IT research firm. Over 250 million patients worldwide have a health record in Epic. The integrated system pulls together data from NJU’s four legacy systems into one single, merged view within NJU’s 60+ practices across New Jersey and Pennsylvania.

As one of the key drivers of becoming a more patient-centric organization, NJU is also using Epic’s patient-facing app, MyChart. Patients can use MyChart to connect with their care team, view their health record, update their demographic and clinical information, request prescription refills and more. This will vastly improve patient accessibility, increasing patient engagement and satisfaction. Amid the COVID-19 pandemic, this offers patients a safer, simplified and much more streamlined contactless check-in process.

“NJU will now have a toolset designed to treat urological conditions and meet the unique needs of their patients,” said Leela Vaughn, Epic Vice President. “As the first large, independent urology group to install Epic on its own, NJU is creating a new option for other independent urology practices to get Epic and benefit from NJU’s expertise.”

“We selected Epic because it allows NJU to perform under one integrated platform. It supports seamless workflows, efficient coordination, and built-in analytics to improve operational efficiencies,” said Derek Grimes, CIO of NJU. “We began our Epic project back in June 2019, and this launch represents a significant milestone. In partnership with Epic, this initiative is a testament to our amazing NJU Epic team consisting of IT, clinicians, physician champions and Epic Super Users across the entire organization. Epic will revolutionize and transform the daily interactions within our practices, facilitate better patient care, and vastly improve patient outcomes.”

OFFICIAL PRESS RELEASE

 

For more information, contact:

Kathy Meyer
New Jersey Urology, LLC
kmeyer@njurology.com
(973) 453-5652
www.njurology.com

 

###

 

About New Jersey Urology:
NJU is the largest urology practice in the United States. The practice provides complete urologic care and comprehensive individualized treatment at more than 60 convenient locations, including six state-of-the-art Cancer Treatment Centers. Utilizing the latest technology and techniques in the industry, NJU offers advanced urologic care with a personal touch.

About Urology Management Associates:
Urology Management Associates was formed to provide administrative services to New Jersey Urology. UMA enables NJU to continue to focus on providing world-class urology services while remaining a physician-led organization. UMA plans to partner with additional urology groups to provide administrative practice management services in the greater New York metropolitan area with long-term plans to expand nationally.

NJU Physicians Selected as SJ Mag 2020 Top Docs

From sjmagazine.net: “At a time when South Jersey needed medical professionals the most, they showed up. That’s what superheroes do. They do what’s right, and they help people. Because of that, this year’s Top Docs list has taken on new meaning.”

Congratulations to our New Jersey Urology physicians for their selection as Top Doctors in the September 2020 issue of SJ Magazine! Learn more about each ‘top doc’ by clicking on their name below:

Read the complete list here >

Dr. Sanjay Kasturi Designated as Urolift® Center of Excellence

We’re proud to announce that the New Jersey Urology office of Dr. Sanjay Kasturi in Vineland, NJ, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Kasturi has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“This designation recognizes Dr. Sanjay Kasturi as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift System
The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology
A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Public Statement from NJU

Public Statement from New Jersey Urology

26 Jul 2020 News

New Jersey Urology (NJU) is devastated and heartbroken by the tragic incident that occurred at our Mount Laurel office on Friday, July 24, 2020. A patient’s family member​ fatally shot our dear colleague and friend, Stephanie Anne Horton, a patient service representative at the Mount Laurel office, and wounded a waiting patient. The suspect has been charged and is currently in custody.

Stephanie Anne Horton, Beloved friend and colleague“In light of recent events, we have all been going through unspeakable grief and shock in hearing of Stephanie Horton’s passing from this horrific, senseless act of gun violence,” said Scott Ciccarelli, CEO of New Jersey Urology. “We would like to extend our heartfelt condolences and prayers to Stephanie’s family, colleagues and friends. Words can’t express the deep sorrow for the loss of our dear NJU colleague. She will always be remembered fondly as a true friend and loyal employee, and a selfless, courageous hero. Stephanie will leave a special place in our hearts.“

During the shooting, one of our patients was injured from a gunshot wound to her right knee. Her NJU urologist, along with a fellow patient, were at her side until paramedics arrived. She was taken to Cooper University Hospital where she was treated immediately for reconstructive surgery. We are so saddened that she was a victim in this random act of violence, and sincerely hope for her speedy recovery.

This has been such a difficult and traumatic experience, and we can’t put into words how saddened and heartbroken we are feeling right now. We understand that many employees, especially those in the Mount Laurel office, are struggling with the shock and pain from this senseless tragedy. We are providing ongoing grief counseling as needed to provide some comfort and help towards the path of healing.

We have also reached out to patients who were unfortunate witnesses to this heinous and cowardly act of violence. It is our utmost priority that employees and patients feel safe and protected. Additional security presence has been deployed at the Mount Laurel office parking area and building, and we are currently assessing other security measures for all our practices.

In remembrance of Stephanie Horton, we will be lowering flags at all of our NJU facilities (those with flags) at half-staff on Monday, August 3rd.

NJU would like to extend our sincere thanks for the outpouring of support we have received from all of our NJU offices, and many national and local organizations. We are deeply touched by their thoughtfulness and support during this difficult time.

Thank you from NJU:

Advanced Urology Institute
American Urological Association
Chesapeake Urology
City of Hope Surgery
Connecticut Children’s Hospital
Fraternal Order of Police Mt. Laurel Lodge 191
iSalus Healthcare
Jefferson Health
Jersey Urology
LUGPA
Macs Janitorial
Mayo Clinic
Mid Atlantic Stone Center Atlantic Lithotripsy, LLC
Mount Laurel Fire Department
Mount Laurel Police Department
Neotract / Teleflex
North Carolina Cancer Hospital
Phreesia Inc.
Rancocas Anesthesiology
ReclaimAbility Pain Services
Red Lanterns Farms LLC
Specialty Networks (UroGPO)
Street Road Animal Hospital
The Center for Kidney Care
The Stone Center of NJ
United Urology
Virtua Mt. Laurel Family Physicians
Virtua Surgical and Breast Group of Moorestown Virtua
Zamir Equities
ZERO Cancer

____________

Updated August 4, 2020
The GoFundMe page is now closed. For Stephanie Horton created by coworkers on behalf of her family:  https://gf.me/u/yifx5h.

1 2 3 5

Search

+
Skip to content